XinYing Medical Recognized as National High-Tech Enterprise, Strengthening Domestic Multi-Organ Life Support Solutions

magAssist Selected as a High-Tech Enterprise

The Core of the Identification of High-tech Enterprises Focuses onR&D investment intensity, core intellectual property rights, and the ability to transform scientific and technological achievements...and other key dimensions, serving as an important measure of a company's scientific and technological innovation capabilities. Since its establishment, magAssist has always taken "addressing clinical pain points in China, breaking through foreign technological barriers, and achieving independent control of key technologies as well as import substitution" as its core mission. Relying on the comprehensive medical industry ecosystem and innovative resources in Jiangsu Province, magAssist implements "Integration of Medicine and Engineering, Joint Research" development model fully aligns with the accreditation standards for high-tech enterprises. Dr. Xu Boshen, the founder, leverages his top-tier education background from home and abroad, along with over two decades of profound experience in the artificial heart field, to lead the team in building an interdisciplinary innovation platform that deeply integrates cutting-edge international technological concepts with the actual clinical needs in China.Gathering Global Wisdom to Serve China's InnovationIn terms of intellectual property layout, the company has applied for more than 400 patents, among which the core patents focus on addressing domestic technological shortcomings. The majority of new patents added in the past two years serve the iteration and industrial implementation of domestically produced products. Meanwhile, international patent layouts completed in countries such as the United States and Europe have become an extension and testament to China's technological strength. Additionally, the company undertakes...Project Supported by the Science and Technology Achievement Transformation Special Fund of Jiangsu Province, has established stable cooperation with multiple clinical centers in China, forming a virtuous cycle of "R&D - Clinical - Transformation", with the efficiency of technology achievement transformation ranking among the top in the industry.

It is worth mentioning that magAssist's innovative achievements in China have also gained attention and recognition from the global industry —— the company has been shortlisted.Galen Prize "Best Start-up" Nomination，Clinical trial data of NyokAssist® inTCT 2025 International ConferenceThe release has gained positive feedback, and these international responses are not isolated layouts but a natural reflection of China's independent innovation technology reaching globally advanced levels, further demonstrating the strong technical capabilities of China's high-tech enterprises.

This selectionHigh-tech Enterprise, not only brings multiple benefits to magAssist such as policy support, enhanced brand trust, and talent aggregation, but also strengthens the company's commitment to cultivating the domestic market and advancingLocalization Substitution's responsibility and commitment. In the future, magAssist will take this national-level certification as an important opportunity to continuously increase R&D investment in China, focus on overcoming "bottleneck" technologies in the field of multi-organ life support, and further improveMatrix of China-produced Products, Accelerating Core ProductsNational Health Insurance CoverageIn clinical practice, allowing more Chinese patients to benefit from advanced medical technologies with independent innovation.

This honor is not only an authoritative endorsement from the country of the enterprise's innovation strength, but also a responsibility to shoulder.Localization of Medical Devices in ChinaThe responsibility of the times. magAssist will always adhere to the original aspiration of "Technology Moves Life," to meetIn ChinaClinicalRigid DemandAs the fundamental starting point, withCore Technology is Self-ControllableAs the core goal, continuously for our countryHigh-Quality Development of the Medical Device IndustryAdding bricks and tiles to overcome "bottleneck" technologies and achieveHigh-Level Technological Self-Reliance and StrengthInject Strong Momentum, Fully Support the Implementation and Effectiveness of the "Healthy China" Strategy.

-END-